n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with triazoles in 1 studies
Studies (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Trials (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Recent Studies (post-2010) (n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime) | Studies (triazoles) | Trials (triazoles) | Recent Studies (post-2010) (triazoles) |
---|---|---|---|---|---|
88 | 0 | 36 | 25,808 | 2,252 | 13,501 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, L; Li, J; Li, T; Li, Z; Lin, L; Wang, P; Xu, Y; Zhang, Y; Zhao, W | 1 |
1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and triazoles
Article | Year |
---|---|
Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
Topics: Acetylglucosamine; Apoptosis; beta-N-Acetylhexosaminidases; Binding Sites; Caspase 3; Catalytic Domain; Enzyme Inhibitors; Hexosaminidase A; Hexosaminidase B; Humans; Kinetics; Oximes; Phenylcarbamates; Protein Isoforms; Recombinant Proteins; Substrate Specificity; Triazoles | 2012 |